The global Pirfenidone market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

North American market for Pirfenidone is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Pirfenidone is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The major global manufacturers of Pirfenidone include Genentech (Roche), Shionogi, GNI Group, Beijing Continent, Cipla, Lupin Ltd, Zydus Cadila, Glenmark Pharmaceuticals and Koye Pharmaceuticals, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Pirfenidone, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pirfenidone.

Report Scope

The Pirfenidone market size, estimations, and forecasts are provided in terms of sales volume (K Pcs) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Pirfenidone market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Pirfenidone manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Pirfenidone Market Report

Report Metric	Details
Report Name	Pirfenidone Market
Segment by Type	Tablet Capsule Others
Segment by Application	Mild Idiopathic Pulmonary Fibrosis Moderate Idiopathic Pulmonary Fibrosis Others
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Genentech (Roche), Shionogi, GNI Group, Beijing Continent, Cipla, Lupin Ltd, Zydus Cadila, Glenmark Pharmaceuticals, Koye Pharmaceuticals, MSN Laboratories, Wockhardt, Incepta Pharmaceuticals, Unimed Unihealth
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Pirfenidone manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Pirfenidone in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Pirfenidone Market report?

Ans: The main players in the Pirfenidone Market are Genentech (Roche), Shionogi, GNI Group, Beijing Continent, Cipla, Lupin Ltd, Zydus Cadila, Glenmark Pharmaceuticals, Koye Pharmaceuticals, MSN Laboratories, Wockhardt, Incepta Pharmaceuticals, Unimed Unihealth

What are the Application segmentation covered in the Pirfenidone Market report?

Ans: The Applications covered in the Pirfenidone Market report are Mild Idiopathic Pulmonary Fibrosis, Moderate Idiopathic Pulmonary Fibrosis, Others

What are the Type segmentation covered in the Pirfenidone Market report?

Ans: The Types covered in the Pirfenidone Market report are Tablet, Capsule, Others

1 Pirfenidone Market Overview

1.1 Product Overview and Scope of Pirfenidone

1.2 Pirfenidone Segment by Type

1.2.1 Global Pirfenidone Market Value Comparison by Type (2024-2030)

1.2.2 Tablet

1.2.3 Capsule

1.2.4 Others

1.3 Pirfenidone Segment by Application

1.3.1 Global Pirfenidone Market Value by Application: (2024-2030)

1.3.2 Mild Idiopathic Pulmonary Fibrosis

1.3.3 Moderate Idiopathic Pulmonary Fibrosis

1.3.4 Others

1.4 Global Pirfenidone Market Size Estimates and Forecasts

1.4.1 Global Pirfenidone Revenue 2019-2030

1.4.2 Global Pirfenidone Sales 2019-2030

1.4.3 Global Pirfenidone Market Average Price (2019-2030)

1.5 Assumptions and Limitations

2 Pirfenidone Market Competition by Manufacturers

2.1 Global Pirfenidone Sales Market Share by Manufacturers (2019-2024)

2.2 Global Pirfenidone Revenue Market Share by Manufacturers (2019-2024)

2.3 Global Pirfenidone Average Price by Manufacturers (2019-2024)

2.4 Global Pirfenidone Industry Ranking 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Pirfenidone, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Pirfenidone, Product Type & Application

2.7 Pirfenidone Market Competitive Situation and Trends

2.7.1 Pirfenidone Market Concentration Rate

2.7.2 The Global Top 5 and Top 10 Largest Pirfenidone Players Market Share by Revenue

2.7.3 Global Pirfenidone Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

2.8 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Pirfenidone Retrospective Market Scenario by Region

3.1 Global Pirfenidone Market Size by Region: 2019 Versus 2023 Versus 2030

3.2 Global Pirfenidone Global Pirfenidone Sales by Region: 2019-2030

3.2.1 Global Pirfenidone Sales by Region: 2019-2024

3.2.2 Global Pirfenidone Sales by Region: 2025-2030

3.3 Global Pirfenidone Global Pirfenidone Revenue by Region: 2019-2030

3.3.1 Global Pirfenidone Revenue by Region: 2019-2024

3.3.2 Global Pirfenidone Revenue by Region: 2025-2030

3.4 North America Pirfenidone Market Facts & Figures by Country

3.4.1 North America Pirfenidone Market Size by Country: 2019 VS 2023 VS 2030

3.4.2 North America Pirfenidone Sales by Country (2019-2030)

3.4.3 North America Pirfenidone Revenue by Country (2019-2030)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe Pirfenidone Market Facts & Figures by Country

3.5.1 Europe Pirfenidone Market Size by Country: 2019 VS 2023 VS 2030

3.5.2 Europe Pirfenidone Sales by Country (2019-2030)

3.5.3 Europe Pirfenidone Revenue by Country (2019-2030)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Pirfenidone Market Facts & Figures by Country

3.6.1 Asia Pacific Pirfenidone Market Size by Country: 2019 VS 2023 VS 2030

3.6.2 Asia Pacific Pirfenidone Sales by Country (2019-2030)

3.6.3 Asia Pacific Pirfenidone Revenue by Country (2019-2030)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.6.13 Philippines

3.7 Latin America Pirfenidone Market Facts & Figures by Country

3.7.1 Latin America Pirfenidone Market Size by Country: 2019 VS 2023 VS 2030

3.7.2 Latin America Pirfenidone Sales by Country (2019-2030)

3.7.3 Latin America Pirfenidone Revenue by Country (2019-2030)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Pirfenidone Market Facts & Figures by Country

3.8.1 Middle East and Africa Pirfenidone Market Size by Country: 2019 VS 2023 VS 2030

3.8.2 Middle East and Africa Pirfenidone Sales by Country (2019-2030)

3.8.3 Middle East and Africa Pirfenidone Revenue by Country (2019-2030)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 U.A.E

4 Segment by Type

4.1 Global Pirfenidone Sales by Type (2019-2030)

4.1.1 Global Pirfenidone Sales by Type (2019-2024)

4.1.2 Global Pirfenidone Sales by Type (2025-2030)

4.1.3 Global Pirfenidone Sales Market Share by Type (2019-2030)

4.2 Global Pirfenidone Revenue by Type (2019-2030)

4.2.1 Global Pirfenidone Revenue by Type (2019-2024)

4.2.2 Global Pirfenidone Revenue by Type (2025-2030)

4.2.3 Global Pirfenidone Revenue Market Share by Type (2019-2030)

4.3 Global Pirfenidone Price by Type (2019-2030)

5 Segment by Application

5.1 Global Pirfenidone Sales by Application (2019-2030)

5.1.1 Global Pirfenidone Sales by Application (2019-2024)

5.1.2 Global Pirfenidone Sales by Application (2025-2030)

5.1.3 Global Pirfenidone Sales Market Share by Application (2019-2030)

5.2 Global Pirfenidone Revenue by Application (2019-2030)

5.2.1 Global Pirfenidone Revenue by Application (2019-2024)

5.2.2 Global Pirfenidone Revenue by Application (2025-2030)

5.2.3 Global Pirfenidone Revenue Market Share by Application (2019-2030)

5.3 Global Pirfenidone Price by Application (2019-2030)

6 Key Companies Profiled

6.1 Genentech (Roche)

6.1.1 Genentech (Roche) Corporation Information

6.1.2 Genentech (Roche) Description and Business Overview

6.1.3 Genentech (Roche) Pirfenidone Sales, Revenue and Gross Margin (2019-2024)

6.1.4 Genentech (Roche) Pirfenidone Product Portfolio

6.1.5 Genentech (Roche) Recent Developments/Updates

6.2 Shionogi

6.2.1 Shionogi Corporation Information

6.2.2 Shionogi Description and Business Overview

6.2.3 Shionogi Pirfenidone Sales, Revenue and Gross Margin (2019-2024)

6.2.4 Shionogi Pirfenidone Product Portfolio

6.2.5 Shionogi Recent Developments/Updates

6.3 GNI Group

6.3.1 GNI Group Corporation Information

6.3.2 GNI Group Description and Business Overview

6.3.3 GNI Group Pirfenidone Sales, Revenue and Gross Margin (2019-2024)

6.3.4 GNI Group Pirfenidone Product Portfolio

6.3.5 GNI Group Recent Developments/Updates

6.4 Beijing Continent

6.4.1 Beijing Continent Corporation Information

6.4.2 Beijing Continent Description and Business Overview

6.4.3 Beijing Continent Pirfenidone Sales, Revenue and Gross Margin (2019-2024)

6.4.4 Beijing Continent Pirfenidone Product Portfolio

6.4.5 Beijing Continent Recent Developments/Updates

6.5 Cipla

6.5.1 Cipla Corporation Information

6.5.2 Cipla Description and Business Overview

6.5.3 Cipla Pirfenidone Sales, Revenue and Gross Margin (2019-2024)

6.5.4 Cipla Pirfenidone Product Portfolio

6.5.5 Cipla Recent Developments/Updates

6.6 Lupin Ltd

6.6.1 Lupin Ltd Corporation Information

6.6.2 Lupin Ltd Description and Business Overview

6.6.3 Lupin Ltd Pirfenidone Sales, Revenue and Gross Margin (2019-2024)

6.6.4 Lupin Ltd Pirfenidone Product Portfolio

6.6.5 Lupin Ltd Recent Developments/Updates

6.7 Zydus Cadila

6.6.1 Zydus Cadila Corporation Information

6.6.2 Zydus Cadila Description and Business Overview

6.6.3 Zydus Cadila Pirfenidone Sales, Revenue and Gross Margin (2019-2024)

6.4.4 Zydus Cadila Pirfenidone Product Portfolio

6.7.5 Zydus Cadila Recent Developments/Updates

6.8 Glenmark Pharmaceuticals

6.8.1 Glenmark Pharmaceuticals Corporation Information

6.8.2 Glenmark Pharmaceuticals Description and Business Overview

6.8.3 Glenmark Pharmaceuticals Pirfenidone Sales, Revenue and Gross Margin (2019-2024)

6.8.4 Glenmark Pharmaceuticals Pirfenidone Product Portfolio

6.8.5 Glenmark Pharmaceuticals Recent Developments/Updates

6.9 Koye Pharmaceuticals

6.9.1 Koye Pharmaceuticals Corporation Information

6.9.2 Koye Pharmaceuticals Description and Business Overview

6.9.3 Koye Pharmaceuticals Pirfenidone Sales, Revenue and Gross Margin (2019-2024)

6.9.4 Koye Pharmaceuticals Pirfenidone Product Portfolio

6.9.5 Koye Pharmaceuticals Recent Developments/Updates

6.10 MSN Laboratories

6.10.1 MSN Laboratories Corporation Information

6.10.2 MSN Laboratories Description and Business Overview

6.10.3 MSN Laboratories Pirfenidone Sales, Revenue and Gross Margin (2019-2024)

6.10.4 MSN Laboratories Pirfenidone Product Portfolio

6.10.5 MSN Laboratories Recent Developments/Updates

6.11 Wockhardt

6.11.1 Wockhardt Corporation Information

6.11.2 Wockhardt Pirfenidone Description and Business Overview

6.11.3 Wockhardt Pirfenidone Sales, Revenue and Gross Margin (2019-2024)

6.11.4 Wockhardt Pirfenidone Product Portfolio

6.11.5 Wockhardt Recent Developments/Updates

6.12 Incepta Pharmaceuticals

6.12.1 Incepta Pharmaceuticals Corporation Information

6.12.2 Incepta Pharmaceuticals Pirfenidone Description and Business Overview

6.12.3 Incepta Pharmaceuticals Pirfenidone Sales, Revenue and Gross Margin (2019-2024)

6.12.4 Incepta Pharmaceuticals Pirfenidone Product Portfolio

6.12.5 Incepta Pharmaceuticals Recent Developments/Updates

6.13 Unimed Unihealth

6.13.1 Unimed Unihealth Corporation Information

6.13.2 Unimed Unihealth Pirfenidone Description and Business Overview

6.13.3 Unimed Unihealth Pirfenidone Sales, Revenue and Gross Margin (2019-2024)

6.13.4 Unimed Unihealth Pirfenidone Product Portfolio

6.13.5 Unimed Unihealth Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Pirfenidone Industry Chain Analysis

7.2 Pirfenidone Key Raw Materials

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Pirfenidone Production Mode & Process

7.4 Pirfenidone Sales and Marketing

7.4.1 Pirfenidone Sales Channels

7.4.2 Pirfenidone Distributors

7.5 Pirfenidone Customers

8 Pirfenidone Market Dynamics

8.1 Pirfenidone Industry Trends

8.2 Pirfenidone Market Drivers

8.3 Pirfenidone Market Challenges

8.4 Pirfenidone Market Restraints

9 Research Finding and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Glenmark Pharmaceuticals

Koye Pharmaceuticals

MSN Laboratories

WOCKHARDT

Incepta Pharmaceuticals

Unimed Unihealth

List of Tables

Table 1. Global Pirfenidone Market Value Comparison by Type (2024-2030) & (US$ Million)

Table 2. Global Pirfenidone Market Value Comparison by Application (2024-2030) & (US$ Million)

Table 3. Global Pirfenidone Market Competitive Situation by Manufacturers in 2023

Table 4. Global Pirfenidone Sales (K Pcs) of Key Manufacturers (2019-2024)

Table 5. Global Pirfenidone Sales Market Share by Manufacturers (2019-2024)

Table 6. Global Pirfenidone Revenue (US$ Million) by Manufacturers (2019-2024)

Table 7. Global Pirfenidone Revenue Share by Manufacturers (2019-2024)

Table 8. Global Market Pirfenidone Average Price (USD/Pcs) of Key Manufacturers (2019-2024)

Table 9. Global Key Players of Pirfenidone, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Pirfenidone, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Pirfenidone, Product Type & Application

Table 12. Global Key Manufacturers of Pirfenidone, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Pirfenidone by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pirfenidone as of 2023)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Pirfenidone Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 17. Global Pirfenidone Sales by Region (2019-2024) & (K Pcs)

Table 18. Global Pirfenidone Sales Market Share by Region (2019-2024)

Table 19. Global Pirfenidone Sales by Region (2025-2030) & (K Pcs)

Table 20. Global Pirfenidone Sales Market Share by Region (2025-2030)

Table 21. Global Pirfenidone Revenue by Region (2019-2024) & (US$ Million)

Table 22. Global Pirfenidone Revenue Market Share by Region (2019-2024)

Table 23. Global Pirfenidone Revenue by Region (2025-2030) & (US$ Million)

Table 24. Global Pirfenidone Revenue Market Share by Region (2025-2030)

Table 25. North America Pirfenidone Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 26. North America Pirfenidone Sales by Country (2019-2024) & (K Pcs)

Table 27. North America Pirfenidone Sales by Country (2025-2030) & (K Pcs)

Table 28. North America Pirfenidone Revenue by Country (2019-2024) & (US$ Million)

Table 29. North America Pirfenidone Revenue by Country (2025-2030) & (US$ Million)

Table 30. Europe Pirfenidone Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 31. Europe Pirfenidone Sales by Country (2019-2024) & (K Pcs)

Table 32. Europe Pirfenidone Sales by Country (2025-2030) & (K Pcs)

Table 33. Europe Pirfenidone Revenue by Country (2019-2024) & (US$ Million)

Table 34. Europe Pirfenidone Revenue by Country (2025-2030) & (US$ Million)

Table 35. Asia Pacific Pirfenidone Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 36. Asia Pacific Pirfenidone Sales by Region (2019-2024) & (K Pcs)

Table 37. Asia Pacific Pirfenidone Sales by Region (2025-2030) & (K Pcs)

Table 38. Asia Pacific Pirfenidone Revenue by Region (2019-2024) & (US$ Million)

Table 39. Asia Pacific Pirfenidone Revenue by Region (2025-2030) & (US$ Million)

Table 40. Latin America Pirfenidone Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Latin America Pirfenidone Sales by Country (2019-2024) & (K Pcs)

Table 42. Latin America Pirfenidone Sales by Country (2025-2030) & (K Pcs)

Table 43. Latin America Pirfenidone Revenue by Country (2019-2024) & (US$ Million)

Table 44. Latin America Pirfenidone Revenue by Country (2025-2030) & (US$ Million)

Table 45. Middle East & Africa Pirfenidone Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 46. Middle East & Africa Pirfenidone Sales by Country (2019-2024) & (K Pcs)

Table 47. Middle East & Africa Pirfenidone Sales by Country (2025-2030) & (K Pcs)

Table 48. Middle East & Africa Pirfenidone Revenue by Country (2019-2024) & (US$ Million)

Table 49. Middle East & Africa Pirfenidone Revenue by Country (2025-2030) & (US$ Million)

Table 50. Global Pirfenidone Sales (K Pcs) by Type (2019-2024)

Table 51. Global Pirfenidone Sales (K Pcs) by Type (2025-2030)

Table 52. Global Pirfenidone Sales Market Share by Type (2019-2024)

Table 53. Global Pirfenidone Sales Market Share by Type (2025-2030)

Table 54. Global Pirfenidone Revenue (US$ Million) by Type (2019-2024)

Table 55. Global Pirfenidone Revenue (US$ Million) by Type (2025-2030)

Table 56. Global Pirfenidone Revenue Market Share by Type (2019-2024)

Table 57. Global Pirfenidone Revenue Market Share by Type (2025-2030)

Table 58. Global Pirfenidone Price (USD/Pcs) by Type (2019-2024)

Table 59. Global Pirfenidone Price (USD/Pcs) by Type (2025-2030)

Table 60. Global Pirfenidone Sales (K Pcs) by Application (2019-2024)

Table 61. Global Pirfenidone Sales (K Pcs) by Application (2025-2030)

Table 62. Global Pirfenidone Sales Market Share by Application (2019-2024)

Table 63. Global Pirfenidone Sales Market Share by Application (2025-2030)

Table 64. Global Pirfenidone Revenue (US$ Million) by Application (2019-2024)

Table 65. Global Pirfenidone Revenue (US$ Million) by Application (2025-2030)

Table 66. Global Pirfenidone Revenue Market Share by Application (2019-2024)

Table 67. Global Pirfenidone Revenue Market Share by Application (2025-2030)

Table 68. Global Pirfenidone Price (USD/Pcs) by Application (2019-2024)

Table 69. Global Pirfenidone Price (USD/Pcs) by Application (2025-2030)

Table 70. Genentech (Roche) Corporation Information

Table 71. Genentech (Roche) Description and Business Overview

Table 72. Genentech (Roche) Pirfenidone Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)

Table 73. Genentech (Roche) Pirfenidone Product

Table 74. Genentech (Roche) Recent Developments/Updates

Table 75. Shionogi Corporation Information

Table 76. Shionogi Description and Business Overview

Table 77. Shionogi Pirfenidone Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)

Table 78. Shionogi Pirfenidone Product

Table 79. Shionogi Recent Developments/Updates

Table 80. GNI Group Corporation Information

Table 81. GNI Group Description and Business Overview

Table 82. GNI Group Pirfenidone Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)

Table 83. GNI Group Pirfenidone Product

Table 84. GNI Group Recent Developments/Updates

Table 85. Beijing Continent Corporation Information

Table 86. Beijing Continent Description and Business Overview

Table 87. Beijing Continent Pirfenidone Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)

Table 88. Beijing Continent Pirfenidone Product

Table 89. Beijing Continent Recent Developments/Updates

Table 90. Cipla Corporation Information

Table 91. Cipla Description and Business Overview

Table 92. Cipla Pirfenidone Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)

Table 93. Cipla Pirfenidone Product

Table 94. Cipla Recent Developments/Updates

Table 95. Lupin Ltd Corporation Information

Table 96. Lupin Ltd Description and Business Overview

Table 97. Lupin Ltd Pirfenidone Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)

Table 98. Lupin Ltd Pirfenidone Product

Table 99. Lupin Ltd Recent Developments/Updates

Table 100. Zydus Cadila Corporation Information

Table 101. Zydus Cadila Description and Business Overview

Table 102. Zydus Cadila Pirfenidone Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)

Table 103. Zydus Cadila Pirfenidone Product

Table 104. Zydus Cadila Recent Developments/Updates

Table 105. Glenmark Pharmaceuticals Corporation Information

Table 106. Glenmark Pharmaceuticals Description and Business Overview

Table 107. Glenmark Pharmaceuticals Pirfenidone Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)

Table 108. Glenmark Pharmaceuticals Pirfenidone Product

Table 109. Glenmark Pharmaceuticals Recent Developments/Updates

Table 110. Koye Pharmaceuticals Corporation Information

Table 111. Koye Pharmaceuticals Description and Business Overview

Table 112. Koye Pharmaceuticals Pirfenidone Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)

Table 113. Koye Pharmaceuticals Pirfenidone Product

Table 114. Koye Pharmaceuticals Recent Developments/Updates

Table 115. MSN Laboratories Corporation Information

Table 116. MSN Laboratories Description and Business Overview

Table 117. MSN Laboratories Pirfenidone Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)

Table 118. MSN Laboratories Pirfenidone Product

Table 119. MSN Laboratories Recent Developments/Updates

Table 120. Wockhardt Corporation Information

Table 121. Wockhardt Description and Business Overview

Table 122. Wockhardt Pirfenidone Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)

Table 123. Wockhardt Pirfenidone Product

Table 124. Wockhardt Recent Developments/Updates

Table 125. Incepta Pharmaceuticals Corporation Information

Table 126. Incepta Pharmaceuticals Description and Business Overview

Table 127. Incepta Pharmaceuticals Pirfenidone Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)

Table 128. Incepta Pharmaceuticals Pirfenidone Product

Table 129. Incepta Pharmaceuticals Recent Developments/Updates

Table 130. Unimed Unihealth Corporation Information

Table 131. Unimed Unihealth Description and Business Overview

Table 132. Unimed Unihealth Pirfenidone Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)

Table 133. Unimed Unihealth Pirfenidone Product

Table 134. Unimed Unihealth Recent Developments/Updates

Table 135. Key Raw Materials Lists

Table 136. Raw Materials Key Suppliers Lists

Table 137. Pirfenidone Distributors List

Table 138. Pirfenidone Customers List

Table 139. Pirfenidone Market Trends

Table 140. Pirfenidone Market Drivers

Table 141. Pirfenidone Market Challenges

Table 142. Pirfenidone Market Restraints

Table 143. Research Programs/Design for This Report

Table 144. Key Data Information from Secondary Sources

Table 145. Key Data Information from Primary Sources

List of Figures

Figure 1. Product Picture of Pirfenidone

Figure 2. Global Pirfenidone Market Value Comparison by Type (2024-2030) & (US$ Million)

Figure 3. Global Pirfenidone Market Share by Type in 2023 & 2030

Figure 4. Tablet Product Picture

Figure 5. Capsule Product Picture

Figure 6. Others Product Picture

Figure 7. Global Pirfenidone Market Value Comparison by Application (2024-2030) & (US$ Million)

Figure 8. Global Pirfenidone Market Share by Application in 2023 & 2030

Figure 9. Mild Idiopathic Pulmonary Fibrosis

Figure 10. Moderate Idiopathic Pulmonary Fibrosis

Figure 11. Others

Figure 12. Global Pirfenidone Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 13. Global Pirfenidone Market Size (2019-2030) & (US$ Million)

Figure 14. Global Pirfenidone Sales (2019-2030) & (K Pcs)

Figure 15. Global Pirfenidone Average Price (USD/Pcs) & (2019-2030)

Figure 16. Pirfenidone Report Years Considered

Figure 17. Pirfenidone Sales Share by Manufacturers in 2023

Figure 18. Global Pirfenidone Revenue Share by Manufacturers in 2023

Figure 19. The Global 5 and 10 Largest Pirfenidone Players: Market Share by Revenue in 2023

Figure 20. Pirfenidone Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023

Figure 21. Global Pirfenidone Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Figure 22. North America Pirfenidone Sales Market Share by Country (2019-2030)

Figure 23. North America Pirfenidone Revenue Market Share by Country (2019-2030)

Figure 24. U.S. Pirfenidone Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 25. Canada Pirfenidone Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 26. Europe Pirfenidone Sales Market Share by Country (2019-2030)

Figure 27. Europe Pirfenidone Revenue Market Share by Country (2019-2030)

Figure 28. Germany Pirfenidone Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 29. France Pirfenidone Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 30. U.K. Pirfenidone Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 31. Italy Pirfenidone Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 32. Russia Pirfenidone Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 33. Asia Pacific Pirfenidone Sales Market Share by Region (2019-2030)

Figure 34. Asia Pacific Pirfenidone Revenue Market Share by Region (2019-2030)

Figure 35. China Pirfenidone Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 36. Japan Pirfenidone Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 37. South Korea Pirfenidone Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 38. India Pirfenidone Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 39. Australia Pirfenidone Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 40. Taiwan Pirfenidone Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 41. Indonesia Pirfenidone Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 42. Thailand Pirfenidone Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 43. Malaysia Pirfenidone Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 44. Philippines Pirfenidone Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 45. Latin America Pirfenidone Sales Market Share by Country (2019-2030)

Figure 46. Latin America Pirfenidone Revenue Market Share by Country (2019-2030)

Figure 47. Mexico Pirfenidone Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 48. Brazil Pirfenidone Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 49. Argentina Pirfenidone Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 50. Middle East & Africa Pirfenidone Sales Market Share by Country (2019-2030)

Figure 51. Middle East & Africa Pirfenidone Revenue Market Share by Country (2019-2030)

Figure 52. Turkey Pirfenidone Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 53. Saudi Arabia Pirfenidone Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 54. U.A.E Pirfenidone Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 55. Global Sales Market Share of Pirfenidone by Type (2019-2030)

Figure 56. Global Revenue Market Share of Pirfenidone by Type (2019-2030)

Figure 57. Global Pirfenidone Price (USD/Pcs) by Type (2019-2030)

Figure 58. Global Sales Market Share of Pirfenidone by Application (2019-2030)

Figure 59. Global Revenue Market Share of Pirfenidone by Application (2019-2030)

Figure 60. Global Pirfenidone Price (USD/Pcs) by Application (2019-2030)

Figure 61. Pirfenidone Value Chain

Figure 62. Pirfenidone Production Process

Figure 63. Channels of Distribution (Direct Vs Distribution)

Figure 64. Distributors Profiles

Figure 65. Bottom-up and Top-down Approaches for This Report

Figure 66. Data Triangulation

Figure 67. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Afidopyropen Market Research Report 2024

Global Nitrendipine Market Research Report 2025

Global Flurbiprofen Market Research Report 2024

Global Flutriafol Market Research Report 2025

Global Sparfloxacin Market Research Report 2024

Global Nitisinone Drug Market Research Report 2024

Global Fluticasone Market Research Report 2024

Global Prometryn Market Research Report 2025

Global Rilpivirine Market Research Report 2024

Global Urapidil Market Research Report 2024

Global Prednisone Market Research Report 2025

Global Dabrafenib Market Research Report 2025

Global Difenuron Market Research Report 2025

Global Pirfenidone Tablets Market Research Report 2024

Global Cyflufenamid Market Research Report 2024

Global Revefenacin Market Research Report 2024

Global Zofenopril Market Research Report 2025

Global Perflubron Market Research Report 2025

Global 4 Bromopyridazine Market Research Report 2024

RELATED REPORTS

Global Enhanced Hollow-Fiber Membrane Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-19T19555

Mon Jun 09 00:00:00 UTC 2025

Add to Cart

Global Disposable Wave Bioreactor Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-30T17927

Mon Jun 09 00:00:00 UTC 2025

Add to Cart

Global Loperamide Hydrochloride Capsules Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-18L19449

Mon Jun 09 00:00:00 UTC 2025

Add to Cart

Global Metabolite Chemistry Reagents Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031

120 Pages

Type: Report

Code: QYRE-Auto-14103

Mon Jun 09 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions